Skip to content
Clinical Trials – home
Verifiedinfo

Dr. med. Joachim Springub Facharzt fuer Neurologie u. Psychiatrie Zusatzbezeichnung Psychotherapie Wolfgang Schwarz Facharzt fuer Neurologie Zusatzbezeichnung Psychotherapie Partnerschaft

Germany Lange Strasse 25, 26655 Westerstede, Germany

  • 1 trial recruiting
  • Migraine · Migraine without aura · Migraine with aura
  • Adult patients

About Specializations

Dr. med. Joachim Springub Facharzt fuer Neurologie u. Psychiatrie Zusatzbezeichnung Psychotherapie Wolfgang Schwarz Facharzt fuer Neurologie Zusatzbezeichnung Psychotherapie Partnerschaft in Westerstede, Germany specialises in clinical trials of conditions such as Migraine, Migraine without aura, Migraine with aura, Dementia Alzheimer's type, and other specialisations. This site conducts important research.

Main research areas of the site

Nervous System Diseases and Headache Disorders

At Privatpraxis Dr. med. J. Springub, Studienzentrum Nord-West, clinical research in neurology focuses strongly on migraine and related conditions. The studies are exploring ways to better prevent and manage different forms of headache, while also looking at longer-term safety and treatment benefit for people living with persistent symptoms.

  • Prevention of chronic migraine and episodic migraine
  • Research on medication overuse headache and menstrual migraine
  • Evaluation of new and continued migraine treatment options

These trials aim to improve symptom control, support everyday functioning, and expand access to therapies for patients affected by complex headache disorders.

Psychiatry and Psychology

The site also contributes to research in mental disorders, with studies centered on schizophrenia and its cognitive effects. This work is designed to gather additional safety information and to better understand treatment value for people who have already taken part in earlier research.

  • Safety follow-up in schizophrenia
  • Support for patients with cognitive impairment
  • Assessment of ongoing treatment benefit in psychiatric care

Overall, the psychiatric trials focus on improving long-term care options and maintaining access to promising therapies for patients with ongoing needs.

Neurological Disease Research and Continued Access Studies

Research at this German clinical site includes studies for broader neurological diseases, especially for patients who have already been enrolled in earlier sponsor-led programs. These trials are aimed at maintaining treatment access and observing how well ongoing therapy supports people living with chronic neurological conditions.

  • Continued treatment for multiple sclerosis
  • Ongoing access for patients with a neurological disease
  • Patient-focused evaluation of treatment impact

In particular, the work includes multiple sclerosis research that examines the physical impact of the disease from the patient’s perspective while supporting continued care.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Lange Strasse 2526655 WesterstedeGermany
Recruiting now
1 trial
Conditions studied
10
Partner status
Verified

More sites in WesterstedeGermany

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

9 clinical trials

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Rotigotine
  • Sponsor:Fondazione Santa Lucia
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Ocrelizumab
  • Sponsor:F. Hoffmann-La Roche AG
Countries:GermanyGermany
  • Participants:18–64 years
  • Substances:Iclepertin
  • Sponsor:Boehringer Ingelheim International GmbH
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Paracetamol
  • Sponsor:Merz Therapeutics GmbH
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years
  • Substances:Fenebrutinib
  • Sponsor:F. Hoffmann-La Roche AG
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Eptinezumab
  • Sponsor:H. Lundbeck A/S

Migraine+3

Not recruiting
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Atogepant
  • Sponsor:AbbVie Deutschland GmbH & Co. KG
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Atogepant
  • Sponsor:AbbVie Deutschland GmbH & Co. KG
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.